Back to today’s briefing

Story perspectives

BD Plans Strategic Split for $17.8 Billion Revenue Target

2/6/2025

32 3

Summary

Story summary

Becton, Dickinson and Company (BD) is set to carve out its Biosciences and Diagnostic Solutions business, aiming for sharper focus and growth. The newly streamlined BD targets an impressive $17.8 billion in revenue for fiscal 2024, while the separated unit aspires to reach $3.4 billion. This strategic split is anticipated to be completed by 2026.

1 of 1

Story summary

Becton, Dickinson and Company (BD) is set to carve out its Biosciences and Diagnostic Solutions business, aiming for sharper focus and growth. The newly streamlined BD targets an impressive $17.8 billion in revenue for fiscal 2024, while the separated unit aspires to reach $3.4 billion. This strategic split is anticipated to be completed by 2026.